Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets
Jing Yang, Jin Xu, Wei Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 140

Showing 1-25 of 140 citing articles:

Epigenetic modifications: Key players in cancer heterogeneity and drug resistance
Hana Q. Sadida, Alanoud Abdulla, Sara Al Marzooqi, et al.
Translational Oncology (2023) Vol. 39, pp. 101821-101821
Open Access | Times Cited: 46
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
Fangfang Liu, Jingyu Chen, Kai Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 31
Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities
Nanhao Yin, Xintong Li, Xuanwei Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment
Linlin Zhou, Danny Yu
Pharmacological Research (2024) Vol. 204, pp. 107205-107205
Open Access | Times Cited: 15
Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on Biomarkers
Αreti Strati, Christos Adamopoulos, Ioannis Kotsantis, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1235-1235
Open Access | Times Cited: 2
Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m5C modification of SLC7A11 mRNA
Shuai-Jun Chen, Jun Zhang, Ting Zhou, et al.
Redox Biology (2023) Vol. 69, pp. 102975-102975
Open Access | Times Cited: 35
The functions and mechanisms of post-translational modification in protein regulators of RNA methylation: Current status and future perspectives
Youming Chen, Zuli Jiang, Ying Yang, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126773-126773
Closed Access | Times Cited: 22
Epigenome editing for targeted DNA (de)methylation: a new perspective in modulating gene expression
Karishma Seem, Simardeep Kaur, Suresh Kumar, et al.
Critical Reviews in Biochemistry and Molecular Biology (2024) Vol. 59, Iss. 1-2, pp. 69-98
Closed Access | Times Cited: 13
The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment
Mengdan Xu, Shenglong Li
Cancer Letters (2024) Vol. 593, pp. 216969-216969
Closed Access | Times Cited: 11
Dual inhibitors of DNMT and HDAC induce viral mimicry to induce antitumour immunity in breast cancer
Wenjun Huang, Qingyun Zhu, Zhichao Shi, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Recurrent Glioblastoma—Molecular Underpinnings and Evolving Treatment Paradigms
Christopher Chang, Velina Chavarro, Jakob V. E. Gerstl, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6733-6733
Open Access | Times Cited: 9
Delivery of natural products via polysaccharide-based nanocarriers for cancer therapy: A review on recent advances and future challenges
Yingjie Jiang, Chunmei Yan, Minghao Li, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 135072-135072
Closed Access | Times Cited: 9
M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets
Mengzhen Han, Qibo Huang, Xinxin Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1238-1255
Open Access | Times Cited: 8
Epigenetic regulation of tumor immunity
Lizhi Pang, Fei Zhou, Yang Liu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 12
Open Access | Times Cited: 8
The molecular code of kidney cancer: A path of discovery for gene mutation and precision therapy
Deqian Xie, Guandu Li, Zhonghua Zheng, et al.
Molecular Aspects of Medicine (2025) Vol. 101, pp. 101335-101335
Open Access | Times Cited: 1
Advancing precision cancer immunotherapy drug development, administration, and response prediction with AI-enabled Raman spectroscopy
Jay Chadokiya, Kai Chang, Saurabh Sharma, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Harnessing phytochemicals: innovative strategies to enhance cancer immunotherapy
Qianru Zhu, Ruonan Zhang, Min Jin Ha, et al.
Drug Resistance Updates (2025) Vol. 79, pp. 101206-101206
Open Access | Times Cited: 1
5-Hydroxymethylcytosine modifications in circulating cell-free DNA: frontiers of cancer detection, monitoring, and prognostic evaluation
Danjun Song, Zhou Zhang, Jiaping Zheng, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Decoding the ribosome's hidden language: rRNA modifications as key players in cancer dynamics and targeted therapies
Li Cui, Jiarong Zheng, Yunfan Lin, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 5
Open Access | Times Cited: 7
Precision treatment of pancreatic ductal adenocarcinoma
Hongyun Wei, He Ren
Cancer Letters (2024) Vol. 585, pp. 216636-216636
Closed Access | Times Cited: 6
Targeting KDM4 family epigenetically triggers antitumour immunity via enhancing tumour‐intrinsic innate sensing and immunogenicity
Mayu Sun, Xiaoyu Han, Jinyang Li, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 6
Epigenetic regulation of tumor-immune symbiosis in glioma
Yang Liu, Heba Ali, Fatima Khan, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 5, pp. 429-442
Open Access | Times Cited: 6
Advances in Melanoma: From Genetic Insights to Therapeutic Innovations
Fernando Valdez-Salazar, Luis Alberto Jiménez-Del Río, Jorge Ramón Padilla‐Gutiérrez, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1851-1851
Open Access | Times Cited: 6
Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 13
Structure–Activity Relationship of PAD4 Inhibitors and Their Role in Tumor Immunotherapy
Yijiang Jia, Renbo Jia, Ayijiang Taledaohan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 335-335
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top